Dr. Seymour Discusses the Results of the PRIMA Study

Natalie Portman having anxiety #natalieportman #shorts #shortsfeed #viral #subscribetomychannelПодробнее

Dr. Seymour Diamond -A Pioneer in Headache MedicineПодробнее

Dr. John Seymour on the Efficacy of ABT-199 in High-Risk CLLПодробнее

FOLL12 trial: response-oriented maintenance therapy for advanced follicular lymphomaПодробнее

Former Pres. Obama trolls Pres. BidenПодробнее

PRIMA: Frontline Niraparib Maintenance Therapy in Ovarian CancerПодробнее

Clinical Data From the Phase III PRIMA trialПодробнее

Dr. Seymour Discusses Rationale for MURANO Study in CLLПодробнее

Dr Seymour Her PassionПодробнее

Dr. Matulonis on Individualized Dosing of Niraparib in Ovarian CancerПодробнее

Dr. Kaplan on the RELEVANCE Trial in Follicular LymphomaПодробнее

British Health Specialist Exposes Sleep SupplementsПодробнее

2013 Annual Hematology Meeting: Lymphoma - Rituximab maintenance therapyПодробнее

Niraparib in newly diagnosed advanced ovarian cancer: PRIMA resultsПодробнее

Niraparib as maintenance for platinum-sensitive ovarian cancer - results from ENGOT-OV16/NOVA trialПодробнее

Dr. Moore on Early-Phase Data With Mirvetuximab Soravtansine in Ovarian CancerПодробнее

Is there long term benefit from maintenance rituximab for lymphoma patients?Подробнее

Dana Chase, MD, shares details about PRIMA and PAOLA clinical studies regarding ovarian cancerПодробнее

Novel Bcl-2 specific inhibitor - results show substantial activity and responses in high-risk CLLПодробнее